Skip to content
RDL Network logo
TCT-36 One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSORB EXTEND Trials. — Takashi Muramatsu (2013) | RDL Network